Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial to Assess Safety and Tolerability of Daclizumab in HIV-Infected Individuals

NCT00080431 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00080431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00080431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial to Assess Safety and Tolerability of Daclizumab in HIV-Infected Individuals
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 1
Overall status
Completed
Start date
March 26, 2004
Completion date
December 28, 2007
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections